The Long Haul
For some people infected with COVID-19, the disease does not end with the swift resolution of all symptoms.
Last year, Sudipto Mukherjee, MD, MPH, a...
Examining the Blood-Brain Barrier
The prognosis for patients with non-Hodgkin lymphoma (NHL) who develop central nervous system (CNS) relapse is dismal, and there are few clear answers about...
Charting the Myeloma Immunotherapy Landscape
A bevy of forthcoming immunotherapies for multiple myeloma over the next few years raises hopes, as well as questions about combinations, sequencing, and potential...
Instant Access: Alarming or Empowering?
As the 21st Century Cures Act’s information blocking requirements go into effect, clinicians face the realities of increased patient access.
Years ago, to share medical...
Use of Transplant Persists as Appropriate Option in PTCLs
Backed by experience, but not randomized data, most institutions have established practices for transplant in patients with peripheral T-cell lymphomas.
No consensus exists on the...
The Doctor Is Out
For doctors considering a career outside of patient care, experts offer advice for avoiding common pitfalls in the second of a two-part series
With the...
From Bench to Bedside
More universities are focusing efforts on technology transfer and industry partnerships to bring new therapies to market
Technology transfer, or the commercialization of scientific discoveries,...
Leaving the Bedside
Career opportunities for doctors extend far beyond the patient care setting.
When choosing to become a physician, most people expect to spend their entire working...
What Makes a Good Leader?
Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.
As cases...
Hematology and the Transgender Patient
An estimated 1.4 million U.S. adults (0.6% of all adults) self-report as transgender; yet, to date, little research has been conducted to understand cancer...
Current Issue
April 2021 Volume 7 Issue 5
This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.